Article by High! Canada
High! Canada Magazine recently connected with Medigreen to discuss the rising popularity of CBD-based products in Canada. Medigreen is a Vancouver based company seeking through its various ventures to provide consumers with better quality & healthy cannabis (CBD only) and other plant-based medicines. They offer honest products, conduct fair trade and are a socially responsible company that practices an organic mindset, ethical philosophies, holistic values as they carry out their social mission.
Cannabidiol or as it is commonly referenced -CBD—is one of 80 known Cannabinoid compounds found in the Cannabis plant. These are compounds that have significant medical benefits but do not make people feel “stoned” and can actually counteract the psychoactivity of THC. The fact that CBD-rich cannabis is non-psychoactive or less psychoactive than THC-dominant strains makes it an appealing option for patients looking for relief from inlammation, pain, anxiety, psychosis, seizures, spasms, and other conditions without disconcerting feelings of lethargy or dysphoria.
Scientific and clinical research—much of it sponsored by the US and Canadian government—underscores CBD’s potential as a treatment for a wide range of conditions, CBD has demonstrable neuroprotective and neurogenic effects, and its anti-cancer properties are currently being investigated at several academic research centers and private companies around the world. Further evidence suggests that CBD is safe even at high doses.
In the last 20 years, natural cannabinoid receptor systems have been discovered in the human body. It is binding to these receptors that cannabinoids produce their pharmacological effects. There are two types of cannabinoid receptors in humans, CB1 & CB2. CB1 receptors are present in the brain, spinal cord, and certain peripheral tissues. CB2 receptors are found primarily in immune tissues.
Medigreen is Phytoceutical innovator specializing in the development and distribution of pharmaceutical, health and wellness products. Medigreen is a pioneer of many firsts including the commercialization of a 99%+ pure, Bioactive pharmaceutical-grade CBD derived from the hemp plant in Canada. Medigreen’s products are THC Free, Non-GMO, Nano-Amplified and are all third party Lab Tested to ensure the utmost quality.
This raw ingredient has been further developed using microencapsulation and nanotechnologies to maximize bioavailability and enable water-soluble applications of hemp derivatives for the highest quality consumables and topical skin care products.
Bioactivity is what happens when a compound reaches its intended target. At Medigreen we are very focused on presenting consumers with the most effective and convenient methods of consuming CBD.
When you’re using an ingredient to treat a health condition or ailment, or even just maintain general health and wellness, efficacy is everything. Efficacy is most often tied directly to bioavailability; which is the ability of the compound to enter systemic circulation (the bloodstream) so that it can affect cells and tissues.
The easiest compounds for the body to absorb into systemic circulation are those that are water-soluble The national consensus for systemic absorption of lipid (fat/oil) soluble ingredients is somewhere between 10% and 20%, this means only 20% or less of lipids get absorbed into systemic circulation, much lower absorption than water-soluble ingredients.
Based on studies done in the recent past and in both oil and water-soluble versions, Mg for mg there is no question that water-soluble CBD seems to work better; it is absorbed into the bloodstream, cells, and tissues easier, faster and in greater concentration than CBD in oil.
Based on our observations, absorption of water-soluble CBD versus CBD oil is as high as 8:1. In other words, 8 mg of water-soluble CBD gets absorbed for every 1 mg of CBD in oil form.
Medigreen was founded in 2016, by a group who had a tremendous amount of passion for the industry and belief in the medicinal value of Cannabis. The company was launched in Spring 2016 with the sole focus of being the largest Hemp derived CBD finished product and bulk supplier in Canada. Since then the company has grown at a very rapid pace and has developed a large distribution base ranging from many distributors, wholesalers, retailers, bulk formulators and white label clients. Medi g re en currently has 8 employees and growing, with a plan to ramp up production and operations for 2018 and beyond.
Sohe il Samimi’ s journey to becoming a Cannabis Entrepreneur started with a general awareness and understanding of phytoceuticals (plant-based medicines) including Cannabidiol and their value towards human well-being. Soheil’s curiousity was further peaked after discovering that the United States Governement holds a patent(USPTO 6630507) on CBD in which it concludes that Cannabidiol is one of the most effective natural antioxidants and neuroprotectants available. In addition to the patent, various studies had been conducted by Health Canada corroborating the efficacy of Cannabidiol for various health conditions.
These findings combined with the understanding of the importance of a THC-free product as a general wellness medicine to the broader population, could not be ignored. Hemp Derived CBD is a perfect entry vehicle from which you can get the wellness component of Cannabis without the high. Therefore, many people who are not yet open to Cannabis, are able to get the benefits of hemp-derived CBD containing less than 0.2% THC. In addition to CBD, there are many other phytocannabinoids found in hemp that are yet to be properly studied.
Our hemp extracts contain over 80 different phytocannabinoids such as cannabidiol (CBD), CBC, CBG, CBN, etc.. In addition to the cannabinoids naturally present in our agricultural hemp extracts, there are also many other types of natural molecules and phytochemical compounds such as amino acids, carbohydrates, vitamins (including B1, B2, B6, D), fatty acids (including omega 3 & 6), trace minerals (including iron, zinc, calcium, magnesium, potassium), beta-carotene, chlorophyll, lavonoids, ketones, nitrogenous compounds, alkanes, glycosides, pigments, water, and terpenes. We are still in the early stages of studying and identifying the effects of other cannabinoids such as CBC, CBG, CBN, etc. on the endocannabinoid system, both with respect to their individual effects, as well as how they interact with other cannabinoids, which is sometimes referred to as the “Entourage Effec”.